Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

COPD: Mortality and Readmissions in Relation to Number of Admissions with Noninvasive Ventilation

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response

    Research output: Contribution to journalReviewResearchpeer-review

  3. Personality Traits and Mental Symptoms are Associated with Impact of Chronic Obstructive Pulmonary Disease on Patients' Daily life

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Increased respiratory morbidity in individuals with interstitial lung abnormalities

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In severe COPD, patients having survived acute hypercapnic respiratory failure (AHRF) treated with noninvasive ventilation (NIV) have a high mortality and risk of readmissions. The aim was to analyze the prognosis for patients with COPD having survived AHRF and to assess whether previous admissions with NIV predict new ones.We conducted a retrospective follow-up analysis of 201 patients two years after NIV treatment of AHRF. Comparison of time-to-event in patients previously treated with NIV versus patients with no previous NIV treatment. We found a one-year mortality of 33.8% and high risks of: readmission (53.2%), any event (67.7%), and life-threatening events (49.8%). Patients with previous NIV treatments had an increased hazard ratio for life-threatening events: 1.60, p = 0.023 despite having lower in-hospital mortality than patients with no previous NIV treatment (18.9% vs. 33.1%, p = 0.043). We found that having survived one episode of AHRF considerably worsened the prognosis for the affected patients.The prognosis for patients having survived AHRF with NIV treatment is poor: the prognosis worsens with additional episodes of AHRF. Future research and treatment should focus on patients with repeated episodes of AHRF.

Original languageEnglish
JournalCOPD
Volume14
Issue number1
Pages (from-to)30-36
Number of pages7
ISSN1541-2555
DOIs
Publication statusPublished - Feb 2017

    Research areas

  • Journal Article

ID: 52009780